<DOC>
	<DOCNO>NCT02537808</DOCNO>
	<brief_summary>The objective non-interventional study explore safety , effectiveness quality life lenalidomide / dexamethasone first line treatment transplant-ineligible patient multiple myeloma real life setting .</brief_summary>
	<brief_title>Non-interventional Study Lenalidomide / Dexamethasone First Line Therapy Patients With Multiple Myeloma</brief_title>
	<detailed_description>The introduction new drug differently combine conventional chemotherapy low-dose dexamethasone change substantially treatment paradigm patient multiple myeloma . A variety treatment option available elderly patient . To compare efficacy safety continuous lenalidomide combination low-dose dexamethasone ( Rd ) progression vs. Rd 18 cycles/72 week ( Rd18 ) vs. melphalan , prednisone thalidomide ( MPT ) 12 cycles/72 week multicenter , open-label phase III study ( MM-020/IFM 07-01 , FIRST trial ) perform transplant ineligible patient . After market approval lenalidomide previously untreated transplant-ineligible patient multiple myeloma , purpose FIRST-NIS evaluate safety , effectiveness quality life lenalidomide combination dexamethasone first line treatment multiple myeloma real life setting .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Diagnosis multiple myeloma ( 2008 WHO classification ) require treatment ( defined IMWG ) Indication treatment assess treat physician Decision first line combination therapy lenalidomide lowdose dexamethasone No previous systemic therapy multiple myeloma Ineligibility transplantation Aged 18 year old Written inform consent sign The condition risk management plan/pregnancy prevention program ( refer SmPC RevlimidÂ® ) must follow female male patient Other criterion accord SmPC . Special warning precaution SmPC consider treat physician Pregnant breastfeed woman Any objection contraindication accord SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>